The effects of medications on circulating levels of cardiac natriuretic peptides (Q28212913)

Europe PubMed Central

title

The effects of medications on circulating levels of cardiac natriuretic peptides (English)

0 references

1

Richard W Troughton

0 references

Mark Richards

2

A Mark Richards

0 references

Tim Yandle

3

Tim G Yandle

0 references

Chris Frampton

4

Chris M Frampton

0 references

Gary Nicholls

5

Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions

M Gary Nicholls

0 references

language of work or name

English

0 references

publication date

2007

0 references

published in

Annals of Medicine

0 references

volume

39

0 references

issue

4

0 references

page(s)

242-60

0 references

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Introduction of metoprolol increases plasma B-type cardiac natriuretic peptides in mild, stable heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Interactions between the sympathetic nervous system and the cardiac natriuretic peptide system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Relationship between plasma atrial and brain natriuretic peptide concentration and hemodynamic parameters during percutaneous transvenous mitral valvulotomy in patients with mitral stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

The effect of altering haemodynamics on the plasma concentrations of natriuretic peptides in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Effects of enalapril and hydrochlorothiazide on blood pressure, renin-angiotensin system, and atrial natriuretic factor in essential hypertension: a double blind factorial cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Differential effects of antihypertensive drugs on neurohormonal activation: insights from a population-based sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind st

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Increased urinary aquaporin-2 excretion in response to furosemide in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Spironolactone improves diastolic function in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Effects of spironolactone on exercise capacity and neurohormonal factors in patients with heart failure treated with loop diuretics and angiotensin-converting enzyme inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Effect of beta-adrenergic blockade on plasma atrial natriuretic factor and cardiac volumes during exercise in normal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: evidence from a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Influence of drugs and gender on the arterial pulse wave and natriuretic peptide secretion in untreated patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Increased Plasma Concentration of Natriuretic Peptides by Selective β1-Blocker Bisoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Exercise release of cardiac natriuretic peptides is markedly enhanced when patients with coronary artery disease are treated medically by beta-blockers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Opposite effects of losartan and atenolol on natriuretic peptides in patients with hypertension and left ventricular hypertrophy: a LIFE substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Do losartan and atenolol have differential effects on BNP and central haemodynamic parameters?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Carvedilol enhances atrial and brain natriuretic peptide mRNA expression and release in rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Effect of low dose beta blockers on atrial and ventricular (B type) natriuretic factor in heart failure: a double blind, randomised comparison of metoprolol and a third generation vasodilating beta blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during beta-blocker therapy: a potential of hormone-guided treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Atenolol improves ventricular function without changing plasma noradrenaline but decreasing plasma atrial natriuretic factor in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Comparison of treatment effects of bevantolol and metoprolol on cardiac function and natriuretic peptides in patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Reductions in muscle sympathetic nerve activity after long-term metoprolol for dilated cardiomyopathy: preliminary observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Comparison of effects of carvedilol versus metoprolol on cytokine levels in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Neurohormonal activation in heart failure after acute myocardial infarction treated with beta-receptor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Effects of carvedilol on plasma B-type natriuretic peptide concentration and symptoms in patients with heart failure and preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Brain natriuretic peptide response is heterogeneous during beta-blocker therapy for congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Beneficial effect of beta-adrenergic blockade on left ventricular function in haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Candesartan, an angiotensin II receptor blocker, improves left ventricular hypertrophy and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Effects of valsartan and perindopril combination therapy on left ventricular hypertrophy and aortic arterial stiffness in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Atrial natriuretic peptide levels in congestive heart failure in man before and during converting enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Effect of angiotensin-converting enzyme inhibition on sympathetic tone in patients with mild to moderate heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Effects of the angiotensin-converting enzyme inhibitor alacepril on exercise capacity and neurohormonal factors in patients with mild-to-moderate heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Comparison of the effects of omapatrilat and lisinopril on circulating neurohormones and cytokines in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

B-type natriuretic peptide as a marker of the effects of enalapril in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Acute and 3-month treatment effects of candesartan cilexetil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Effects of angiotensin II receptor antagonists on [(123)I]metaiodobenzylguanidine myocardial imaging findings and neurohumoral factors in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Effects of perindopril on cardiac sympathetic nerve activity in patients with congestive heart failure: comparison with enalapril

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Comparative effects of valsartan and enalapril on cardiac sympathetic nerve activity and plasma brain natriuretic peptide in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Within-patient comparison of effects of different dosages of enalapril on functional capacity and neurohormone levels in patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Combined inhibition of endothelin and angiotensin II receptors blocks volume load-induced cardiac hormone release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Combined inhibition of angiotensin II and endothelin suppresses the brain natriuretic peptide response to developing heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Verapamil impairs secretion of stimulated atrial natriuretic factor in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Effects of angiotensin converting enzyme inhibitors and calcium antagonists on atrial natriuretic peptide release and action and on albumin excretion rate in hypertensive insulin-dependent diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Plasma atrial natriuretic peptide levels in essential hypertension after treatment with verapamil

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Double-blind, placebo-controlled crossover comparison of five classes of antihypertensive drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Neurohormones and oxidative stress in nonischemic cardiomyopathy: relationship to survival and the effect of treatment with amlodipine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Effects of cold pressor test on circulating atrial natriuretic peptide 99-126 (ANP) in patients with Raynaud's phenomenon and influence of treatment with magnesium sulphate and nifedipine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Effect of diltiazem on cardiac function assessed by echocardiography and neurohumoral factors after reperfused myocardial infarction without congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Atrial natriuretic peptide in severe heart failure: response to controlled changes in atrial pressures during intravenous nitroglycerin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Acute effect of an alpha 1-adrenoceptor antagonist on urinary sodium excretion, plasma atrial natriuretic peptide, arginine vasopressin, and the renin-aldosterone system in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Plasma atrial natriuretic peptide in essential hypertension after treatment with terazocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Hemodynamic and plasma atrial natriuretic peptide responses to acute digitalis therapy in patients with normal and impaired left ventricular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Neurohumoral response to carmoxirole, a selective dopamine (D2) receptor agonist, in patients with chronic moderate heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Plasma concentrations of atrial and brain natriuretic peptides and cyclic guanosine monophosphate in response to dobutamine infusion in patients with surgically repaired tetralogy of fallot.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

The Ca2+-sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Usefulness of plasma brain natriuretic peptide levels in predicting dobutamine-induced myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Short-term effects of levosimendan and prostaglandin E1 on hemodynamic parameters and B-type natriuretic peptide levels in patients with decompensated chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Effects of serial levosimendan infusions on left ventricular performance and plasma biomarkers of myocardial injury and neurohormonal and immune activation in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Low-dose amiodarone for patients with advanced heart failure who are intolerant of beta-blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Amiodarone decreases plasma brain natriuretic peptide level in patients with heart failure and ventricular tachyarrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Hormonal replacement therapy affects calcitonin gene-related peptide and atrial natriuretic peptide secretion in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Aspirin does not influence the effect of angiotensin-converting enzyme inhibition on left ventricular ejection fraction 3 months after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Clopidogrel is associated with a lesser increase in NT-proBNP when compared to aspirin in patients with ischemic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Adjunctive therapy with low-molecular-weight heparin in patients with chronic heart failure secondary to dilated cardiomyopathy: one-year follow-up results of the randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Histamine inhibits atrial myocytic ANP release via H2receptor-cAMP-protein kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Hormonal, haemodynamic, and subjective effects of intravenously infused indomethacin: no change in the physiological response to hypertonic saline challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Short-term statin treatment improves endothelial function and neurohormonal imbalance in normocholesterolaemic patients with non-ischaemic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Effects of estrogen replacement therapy on natriuretic peptides and blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Estrogen, natriuretic peptides and the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Doxorubicin selectively inhibits brain versus atrial natriuretic peptide gene expression in cultured neonatal rat myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Prospective evaluation of early cardiac damage induced by epirubicin-containing adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Plasma atrial natriuretic peptide and the renin-aldosterone system during long-term administration of the diuretic xipamide in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Insulin sensitivity and atrial natriuretic factor during beta-receptor modulation with celiprolol in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Neuroendocrine changes post myocardial infarction: Effects of xamoterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057

Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701232057